I. Douglas

First name
I.
Middle name
J.
Last name
Douglas
Tazare, J., Wyss, R., Franklin, J. M., Smeeth, L., Evans, S. J. W., Wang, S. V., et al. (2022). Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5412
Douglas, I. J., Cook, C., Chakravarthy, U., Hubbard, R., Fletcher, A. E., & Smeeth, L. (2007). A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology. http://doi.org/10.1016/j.ophtha.2006.09.018
Douglas, I. J., & Smeeth, L. (2008). Exposure to antipsychotics and risk of stroke: self controlled case series study. Bmj. http://doi.org/10.1136/bmj.a1227
Douglas, I. J., Evans, S. J., Pocock, S., & Smeeth, L. (2009). The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med. http://doi.org/10.1371/journal.pmed.1000154
Douglas, I. J., Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., & Smeeth, L. (2012). Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs. Bmj. http://doi.org/10.1136/bmj.e4388
Douglas, I. J., Langham, J., Bhaskaran, K., Brauer, R., & Smeeth, L. (2013). Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.f1936
Douglas, I. J., Bhaskaran, K., Batterham, R. L., & Smeeth, L. (2015). The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12578
Goh, K. L., Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., & Douglas, I. J. (2015). Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12511
Douglas, I. J., Bhaskaran, K., Batterham, R. L., & Smeeth, L. (2015). Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. PLoS Med. http://doi.org/10.1371/journal.pmed.1001925
Matthews, A., Langan, S. M., Douglas, I. J., Smeeth, L., & Bhaskaran, K. (2016). Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. PLoS Med. http://doi.org/10.1371/journal.pmed.1002037